-
Something wrong with this record ?
Interaction of nerve agent antidotes with cholinergic systems
O. Soukup, G. Tobin, UK. Kumar, J. Binder, J. Proska, D. Jun, J. Fusek, K. Kuca,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
- MeSH
- Acetylcholine metabolism MeSH
- Antidotes chemistry metabolism pharmacology MeSH
- Chemical Warfare Agents poisoning MeSH
- Cholinesterases metabolism MeSH
- Humans MeSH
- Organophosphorus Compounds antagonists & inhibitors MeSH
- Organophosphate Poisoning MeSH
- Receptors, Cholinergic metabolism MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
The poisoning with organophosphorus compounds represents a life threatening danger especially in the time of terroristic menace. No universal antidote has been developed yet and other therapeutic approaches not related to reactivation of acetylcholinesterase are being investigated. This review describes the main features of the cholinergic system, cholinergic receptors, cholinesterases and their inhibitors. It also focuses on the organophosphorus nerve agents, their properties, effects and a large part describes various possibilities in treatments, mainly traditional oxime therapies based on reactivation of AChE. Furthermore, non-cholinesterase coupled antidotal effects of the oximes are thoroughly discussed. These antidotal effects principally include oxime interactions with muscarinic and nicotinic receptors.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025843
- 003
- CZ-PrNML
- 005
- 20170621094307.0
- 007
- ta
- 008
- 120817s2010 ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.2174/092986710791111260 $2 doi
- 035 __
- $a (PubMed)20345348
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Soukup, O $u Department of Toxicology, Faculty of Military Health Science, University of Defense Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. soukup.ondrej@seznam.cz
- 245 10
- $a Interaction of nerve agent antidotes with cholinergic systems / $c O. Soukup, G. Tobin, UK. Kumar, J. Binder, J. Proska, D. Jun, J. Fusek, K. Kuca,
- 520 9_
- $a The poisoning with organophosphorus compounds represents a life threatening danger especially in the time of terroristic menace. No universal antidote has been developed yet and other therapeutic approaches not related to reactivation of acetylcholinesterase are being investigated. This review describes the main features of the cholinergic system, cholinergic receptors, cholinesterases and their inhibitors. It also focuses on the organophosphorus nerve agents, their properties, effects and a large part describes various possibilities in treatments, mainly traditional oxime therapies based on reactivation of AChE. Furthermore, non-cholinesterase coupled antidotal effects of the oximes are thoroughly discussed. These antidotal effects principally include oxime interactions with muscarinic and nicotinic receptors.
- 650 _2
- $a acetylcholin $x metabolismus $7 D000109
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antidota $x chemie $x metabolismus $x farmakologie $7 D000931
- 650 _2
- $a chemické bojové látky $x otrava $7 D002619
- 650 _2
- $a cholinesterasy $x metabolismus $7 D002802
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a organofosforové sloučeniny $x antagonisté a inhibitory $7 D009943
- 650 _2
- $a receptory cholinergní $x metabolismus $7 D011950
- 650 _2
- $a otrava organofosfáty $7 D062025
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Tobin, G
- 700 1_
- $a Kumar, U K
- 700 1_
- $a Binder, J
- 700 1_
- $a Proska, J
- 700 1_
- $a Jun, Daniel, $d 1976- $7 xx0040498
- 700 1_
- $a Fusek, J
- 700 1_
- $a Kuca, K
- 773 0_
- $w MED00001274 $t Current medicinal chemistry $x 1875-533X $g Roč. 17, č. 16 (2010), s. 1708-18
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20345348 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20170621094726 $b ABA008
- 999 __
- $a ok $b bmc $g 947885 $s 783189
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 17 $c 16 $d 1708-18 $i 1875-533X $m Current medicinal chemistry $n Curr Med Chem $x MED00001274
- LZP __
- $a Pubmed-20120817/10/03